Expression profile, haplotypes, and activity of GSK3β have been intensively studied in a broad range of psychiatric and neurological diseases, such as schizophrenia, Parkinson’s, and Alzheimer’s diseases [13], and in the context of mood disorders [39]. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.